SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 29, Issue 12, 2011, Pages

Neoadjuvant chemoradiation in rectal cancer: Time to start in a new direction

(2) Mohiuddin, Mohammed a Mohiuddin, Majid M b,c

a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER (Saudi Arabia)

b Northwest Radiation Oncology ^* (United States)

c UNIVERSITY OF TEXAS (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; GEMCITABINE; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; ROTAXANE;

ADJUVANT CHEMOTHERAPY; CELL CYCLE ARREST; CELL POPULATION; CHEMORADIOTHERAPY; DRUG SUBSTITUTION; ESOPHAGUS CANCER; HUMAN; IMMUNE DEFICIENCY; LETTER; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955025103 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2010.34.0935 Document Type: Letter

Times cited : (9)

References (14)

1
- 77950495945
- Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2
- Gé rard JP, Azria D, Gourgou-Bourgade S, et al: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28:1638- 1644, 2010
- (2010) J Clin Oncol , vol.28 , pp. 1638-1644
- Gérard, J.P.¹ Azria, D.² Gourgou-Bourgade, S.³

2
- 69549151596
- Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the studio terapia adiuvante retto (STAR)-01 randomized phase III trial
- abstr CRA4008
- Aschele C, Pinto C, Cordio S, et al: Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the studio terapia adiuvante retto (STAR)-01 randomized phase III trial. J Clin Oncol 27:170s, 2009 (suppl; abstr CRA4008)
- (2009) J Clin Oncol , vol.27 , Issue.SUPPL.
- Aschele, C.¹ Pinto, C.² Cordio, S.³

3
- 84755160772
- Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials
- Weiss C, Arnold D, Dellas K, et al: Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials. Int J Radiat Oncol Biol Phys 78:472-478, 2010
- (2010) Int J Radiat Oncol Biol Phys , vol.78 , pp. 472-478
- Weiss, C.¹ Arnold, D.² Dellas, K.³

4
- 34247847960
- Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer
- DOI 10.1038/ncponc0813, PII NCPONC0813
- Willett CG, Duda DG, di Tomaso E, et al: Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol 4:316-321, 2007 (Pubitemid 46758789)
- (2007) Nature Clinical Practice Oncology , vol.4 , Issue.5 , pp. 316-321
- Willett, C.G.¹ Duda, D.G.² Di Tomaso, E.³ Boucher, Y.⁴ Czito, B.G.⁵ Vujaskovic, Z.⁶ Vlahovic, G.⁷ Bendell, J.⁸ Cohen, K.S.⁹ Hurwitz, H.I.¹⁰ Bentley, R.¹¹ Lauwers, G.Y.¹² Poleski, M.¹³ Wong, T.Z.¹⁴ Paulson, E.¹⁵ Ludwig, K.A.¹⁶ Jain, R.K.¹⁷

5
- 67749097665
- Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: Results of a phase II MARGIT trial
- Horisberger K, Treschl A, Mai S, et al: Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: Results of a phase II MARGIT trial. Int J Radiat Oncol Biol Phys 74:1487-1493, 2009
- (2009) Int J Radiat Oncol Biol Phys , vol.74 , pp. 1487-1493
- Horisberger, K.¹ Treschl, A.² Mai, S.³

6
- 79951922140
- Radiosensitizing drugs: Lessons to be learned from the oxaliplatin story
- author reply e581-583
- Flatmark K, Ree AH: Radiosensitizing drugs: Lessons to be learned from the oxaliplatin story. J Clin Oncol 28:e577-578, 2010; author reply e581-583
- (2010) J Clin Oncol , vol.28
- Flatmark, K.¹ Ree, A.H.²

7
- 42449128805
- Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial
- DOI 10.1001/jama.299.16.1914
- Ajani JA, Winter KA, Gunderson LL, et al: Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 299:1914-1921, 2008 (Pubitemid 351574921)
- (2008) JAMA - Journal of the American Medical Association , vol.299 , Issue.16 , pp. 1914-1921
- Ajani, J.A.¹ Winter, K.A.² Gunderson, L.L.³ Pedersen, J.⁴ Benson III, A.B.⁵ Thomas Jr., C.R.⁶ Mayer, R.J.⁷ Haddock, M.G.⁸ Rich, T.A.⁹ Willett, C.¹⁰

8
- 46149117538
- Adjuvant role for cell death during chemo- and radiotherapy of cancer?
- DOI 10.1586/1744666X.4.1.27
- Rovere-Querini P, Castiglioni A: Adjuvant role for cell death during chemoand radiotherapy of cancer? Expert Rev Clin Immunol 4:27-32, 2008 (Pubitemid 351902494)
- (2008) Expert Review of Clinical Immunology , vol.4 , Issue.1 , pp. 27-32
- Rovere-Querini, P.¹ Castiglioni, A.²

9
- 79960765258
- Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody [in Japanese]
- Shimodaira H, Komine K, Soeda H, et al: Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody [in Japanese]. Gan To Kagaku Ryoho 37:795-798, 2010
- (2010) Gan To Kagaku Ryoho , vol.37 , pp. 795-798
- Shimodaira, H.¹ Komine, K.² Soeda, H.³

10
- 60649087564
- Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis
- Ebos JM, Lee CR, Cruz-Munoz W, et al: Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15:232-239, 2009
- (2009) Cancer Cell , vol.15 , pp. 232-239
- Ebos, J.M.¹ Lee, C.R.² Cruz-Munoz, W.³

11
- 60649106195
- Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
- Pàez-Ribes M, Allen E, Hudock J, et al: Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220-231, 2009
- (2009) Cancer Cell , vol.15 , pp. 220-231
- Pàez-Ribes, M.¹ Allen, E.² Hudock, J.³

12
- 79951977298
- Lessons from the adjuvant bevacizumab trial on colon cancer: What next?
- Van Cutsem E, Lambrechts D, Prenen H, et al: Lessons from the adjuvant bevacizumab trial on colon cancer: What next? J Clin Oncol 29:1-4, 2011
- (2011) J Clin Oncol , vol.29 , pp. 1-4
- Van Cutsem, E.¹ Lambrechts, D.² Prenen, H.³

13
- 39149111633
- Preoperative chemotherapy: Updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27
- DOI 10.1200/JCO.2007.15.0235
- Rastogi P, Anderson SJ, Bear HD, et al: Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 26:778-785, 2008 (Pubitemid 351264391)
- (2008) Journal of Clinical Oncology , vol.26 , Issue.5 , pp. 778-785
- Rastogi, P.¹ Anderson, S.J.² Bear, H.D.³ Geyer, C.E.⁴ Kahlenberg, M.S.⁵ Robidoux, A.⁶ Margolese, R.G.⁷ Hoehn, J.L.⁸ Vogel, V.G.⁹ Dakhil, S.R.¹⁰ Tamkus, D.¹¹ King, K.M.¹² Pajon, E.R.¹³ Wright, M.J.¹⁴ Robert, J.¹⁵ Paik, S.¹⁶ Mamounas, E.P.¹⁷ Wolmark, N.¹⁸

14
- 79951889854
- Impact of overall treatment time on survival and local control in patients with anal cancer: A pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11
- Ben-Josef E, Moughan J, Ajani JA, et al: Impact of overall treatment time on survival and local control in patients with anal cancer: A pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11. J Clin Oncol 28:5061-5066, 2010
- (2010) J Clin Oncol , vol.28 , pp. 5061-5066
- Ben-Josef, E.¹ Moughan, J.² Ajani, J.A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.